Atlas Trials

Inozyme Pharma

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Inozyme Pharma

RecordFirmDate
ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 Deficiency (NCT07473973)Inozyme Pharma2025-03-26
The ENABLE Study: Safety and Efficacy Study of INZ-701 in Patients With ENPP1 Deficiency (NCT06739980)Inozyme Pharma2025-01-31
PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency (NCT06302439)Inozyme Pharma2024-07-25
ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency (NCT06462547)Inozyme Pharma2024-06-19
The SEAPORT 1 Study: Evaluation of the Safety and Tolerability of INZ-701 in Adults With End-Stage Kidney Disease Undergoing Hemodialysis (NCT06283589)Inozyme Pharma2024-02-12
The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency (NCT06046820)Inozyme Pharma2023-11-05
The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency (NCT05734196)Inozyme Pharma2023-06-25
Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency (NCT05050669)Inozyme Pharma2022-06-28
Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE (NCT05030831)Inozyme Pharma2022-04-11
Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 Deficiency (NCT04686175)Inozyme Pharma2021-11-21
Understanding the Spectrum of ENPP1 Deficiency and Acute ABCC6 Deficiency (NCT04372446)Inozyme Pharma2020-05-06
Natural History Study: ENPP1 Deficiency or the Early-Onset Form of ABCC6 Deficiency (NCT07745179)Inozyme Pharma2018-12-05

Track Inozyme Pharma automatically

Every clearance here is in the API, with alerts when new ones post.